Projects that will be considered for Pfizer support will focus on digital diagnostic approaches to help raise suspicion and optimize care for patients with acromegaly or sickle cell disease.

Projects may include but are not limited to Artificial Intelligence/Machine Learning approaches, facial recognition technology, smartphone-based applications, wearables, and/or virtual reality.

See the full RFP here